ALVA10
Alva10 is dedicated to transforming healthcare by creating an economic ecosystem that pulls diagnostic technology into the system, aligning incentives, and optimizing patient outcomes and payer economics. They focus on bridging the knowledge gap between payers and diagnostic companies, promoting precision medicine, and improving market access and reimbursement strategies for diagnostics.
Industries
Nr. of Employees
small (1-50)
Products
Evidence threshold framework and contractual model for payer‑diagnostic alignment
A structured framework to define the minimally acceptable threshold of evidence for coverage and to establish contractual commitments between payers and diagnostic developers that guide data generation and reimbursement.
Evidence threshold framework and contractual model for payer‑diagnostic alignment
A structured framework to define the minimally acceptable threshold of evidence for coverage and to establish contractual commitments between payers and diagnostic developers that guide data generation and reimbursement.
Services
Define minimally acceptable evidence requirements for coverage, align payer and developer expectations, and document contractual commitments to guide data development.
Engage payers to determine coverage, reimbursement rates, and required evidence; create budget impact models and value‑based pricing strategies.
Analyze employer pharmacy and medical benefit spending, identify high‑impact diagnostic use cases, and recommend implementation or pilot strategies to reduce costs and improve outcomes.
Design clinical study programs (retrospective, prospective, RWE) and advise on LDT vs IVD pathways and technical validation requirements to satisfy payer coverage criteria.
Develop and run pilot programs with payers, employers or PBMs to validate clinical and economic impact and create alternative adoption pathways.
Curate precision medicine diagnostic tools and match best‑in‑class technologies to specific payer or employer clinical/economic needs.
Define minimally acceptable evidence requirements for coverage, align payer and developer expectations, and document contractual commitments to guide data development.
Engage payers to determine coverage, reimbursement rates, and required evidence; create budget impact models and value‑based pricing strategies.
Analyze employer pharmacy and medical benefit spending, identify high‑impact diagnostic use cases, and recommend implementation or pilot strategies to reduce costs and improve outcomes.
Design clinical study programs (retrospective, prospective, RWE) and advise on LDT vs IVD pathways and technical validation requirements to satisfy payer coverage criteria.
Develop and run pilot programs with payers, employers or PBMs to validate clinical and economic impact and create alternative adoption pathways.
Curate precision medicine diagnostic tools and match best‑in‑class technologies to specific payer or employer clinical/economic needs.
Expertise Areas
- Market access and reimbursement strategy
- Clinical evidence design and validation planning
- Health economics and budget impact modeling
- Diagnostic commercialization and go‑to‑market
Key Technologies
- Biomarker discovery
- Assay development
- Analytical validation methods
- Clinical validation studies